application's abstract): The University of California, San Diego AIDS Clinical Trials Unit (UCSD ACTU) proposes to continue participation in the Adult AIDS Clinical Trials Group (AACTG). Members of the UCSD ACTU have contributed to the leadership and development of the AACTG scientific agenda. They have designed, implemented and analyzed AACTG trials in antiretroviral therapy, opportunistic infections and outcomes. Laboratory studies conducted by the investigators have increased the understanding of the pathogenesis of HIV disease and complications, particularly in the areas of drug resistance, mycobacteria and cytomegalovirus disease. This group has established a record of patient accrual and retention by creating a program that is recognized by the community as being devoted to improving the lives of HIV-infected individuals. The ACTU has and will continue to make efforts to recruit as study participants women, minorities, and intravenous drug users. UCSD has a good relationship with the community advisory board that ensures community representation and enhances the overall effectiveness of the unit. The scientific contributions of the unit will focus on three aims: First, it will address the development of novel approaches to antiretroviral therapy and the incorporation of nested studies into clinical trials. The nested studies may provide insight into viral dynamics, resistance and reservoirs of HIV infection. Second, complications of HIV infection, which will provide leadership, innovative ideas and laboratory expertise for studies designed to increase understanding of the pathogenesis, prevention and treatment of opportunistic infections and the neurologic complications of HIV disease. Finally, attention will be given to outcomes and adherence, which will contribute expertise to the AACTG effort to evaluate outcome measures across clinical trials and to develop and test interventions, which may improve patient adherence.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project--Cooperative Agreements (U01)
Project #
2U01AI027670-14
Application #
6021945
Study Section
Special Emphasis Panel (ZAI1-PSS-A (S1))
Program Officer
Batzold, Frederick
Project Start
1986-06-30
Project End
2004-12-31
Budget Start
2000-01-01
Budget End
2000-12-31
Support Year
14
Fiscal Year
2000
Total Cost
$1,794,709
Indirect Cost
Name
University of California San Diego
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Beliakova-Bethell, Nadejda; Hezareh, Marjan; Wong, Joseph K et al. (2017) Relative efficacy of T cell stimuli as inducers of productive HIV-1 replication in latently infected CD4 lymphocytes from patients on suppressive cART. Virology 508:127-133
Osorio, Georgina; Hoenigl, Martin; Quartarolo, Jennifer et al. (2017) Evaluation of opt-out inpatient HIV screening at an urban teaching hospital. AIDS Care 29:1014-1018
Dan, Jennifer M; Massanella, Marta; Smith, Davey M et al. (2016) Brief Report: Effect of CMV and HIV Transcription on CD57 and PD-1 T-Cell Expression During Suppressive ART. J Acquir Immune Defic Syndr 72:133-7
Innes, Steve; Abdullah, Kameelah L; Haubrich, Richard et al. (2016) High Prevalence of Dyslipidemia and Insulin Resistance in HIV-infected Prepubertal African Children on Antiretroviral Therapy. Pediatr Infect Dis J 35:e1-7
Vanpouille, Christophe; Introini, Andrea; Morris, Sheldon R et al. (2016) Distinct cytokine/chemokine network in semen and blood characterize different stages of HIV infection. AIDS 30:193-201
Gianella, Sara; Ginocchio, Christine C; Daar, Eric S et al. (2016) Genital Epstein Barr Virus is associated with higher prevalence and persistence of anal human papillomavirus in HIV-infected men on antiretroviral therapy. BMC Infect Dis 16:24
Blumenthal, Jill; Jain, Sonia; Krakower, Douglas et al. (2015) Knowledge is Power! Increased Provider Knowledge Scores Regarding Pre-exposure Prophylaxis (PrEP) are Associated with Higher Rates of PrEP Prescription and Future Intent to Prescribe PrEP. AIDS Behav 19:802-10
Krishnan, Supriya; Schouten, Jeffrey T; Atkinson, Benjamin et al. (2015) Changes in metabolic syndrome status after initiation of antiretroviral therapy. J Acquir Immune Defic Syndr 68:73-80
Massanella, Marta; Gianella, Sara; Schrier, Rachel et al. (2015) Methamphetamine Use in HIV-infected Individuals Affects T-cell Function and Viral Outcome during Suppressive Antiretroviral Therapy. Sci Rep 5:13179
Gianella, Sara; Smith, Davey M; Daar, Eric S et al. (2015) Genital Cytomegalovirus Replication Predicts Syphilis Acquisition among HIV-1 Infected Men Who Have Sex with Men. PLoS One 10:e0130410

Showing the most recent 10 out of 318 publications